FSPKF Statistics
Total Valuation
Fisher & Paykel Healthcare Corporation has a market cap or net worth of 12.66 billion. The enterprise value is 12.68 billion.
Market Cap | 12.66B |
Enterprise Value | 12.68B |
Important Dates
The next estimated earnings date is Thursday, February 27, 2025.
Earnings Date | Feb 27, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +0.85% |
Shares Change (QoQ) | +0.27% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 583.80M |
Valuation Ratios
The trailing PE ratio is 111.46.
PE Ratio | 111.46 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 10.77 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 41.60, with an EV/FCF ratio of 48.18.
EV / Earnings | 111.64 |
EV / Sales | 11.91 |
EV / EBITDA | 41.60 |
EV / EBIT | 53.73 |
EV / FCF | 48.18 |
Financial Position
The company has a current ratio of 2.06, with a Debt / Equity ratio of 0.08.
Current Ratio | 2.06 |
Quick Ratio | 1.03 |
Debt / Equity | 0.08 |
Debt / EBITDA | 0.28 |
Debt / FCF | 0.36 |
Interest Coverage | 29.09 |
Financial Efficiency
Return on equity (ROE) is 9.70% and return on invested capital (ROIC) is 12.60%.
Return on Equity (ROE) | 9.70% |
Return on Assets (ROA) | 10.85% |
Return on Capital (ROIC) | 12.60% |
Revenue Per Employee | 171,737 |
Profits Per Employee | 16,217 |
Employee Count | 7,031 |
Asset Turnover | 0.78 |
Inventory Turnover | 2.15 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +83.63% in the last 52 weeks. The beta is 0.42, so Fisher & Paykel Healthcare Corporation's price volatility has been lower than the market average.
Beta (5Y) | 0.42 |
52-Week Price Change | +83.63% |
50-Day Moving Average | 21.93 |
200-Day Moving Average | 19.27 |
Relative Strength Index (RSI) | 93.09 |
Average Volume (20 Days) | 227 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Fisher & Paykel Healthcare Corporation had revenue of 1.20 billion and earned 113.60 million in profits. Earnings per share was 0.19.
Revenue | 1.20B |
Gross Profit | 729.97M |
Operating Income | 266.59M |
Pretax Income | 191.88M |
Net Income | 113.60M |
EBITDA | 332.27M |
EBIT | 266.59M |
Earnings Per Share (EPS) | 0.19 |
Balance Sheet
The company has 74.21 million in cash and 96.04 million in debt, giving a net cash position of -21.83 million.
Cash & Cash Equivalents | 74.21M |
Total Debt | 96.04M |
Net Cash | -21.83M |
Net Cash Per Share | n/a |
Equity (Book Value) | 1.23B |
Book Value Per Share | 2.10 |
Working Capital | 251.38M |
Cash Flow
In the last 12 months, operating cash flow was 322.09 million and capital expenditures -58.87 million, giving a free cash flow of 263.22 million.
Operating Cash Flow | 322.09M |
Capital Expenditures | -58.87M |
Free Cash Flow | 263.22M |
FCF Per Share | n/a |
Margins
Gross margin is 60.68%, with operating and profit margins of 22.16% and 9.44%.
Gross Margin | 60.68% |
Operating Margin | 22.16% |
Pretax Margin | 15.95% |
Profit Margin | 9.44% |
EBITDA Margin | 27.62% |
EBIT Margin | 22.16% |
FCF Margin | 21.88% |
Dividends & Yields
Fisher & Paykel Healthcare Corporation does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 69.51% |
Buyback Yield | -0.85% |
Shareholder Yield | -0.85% |
Earnings Yield | n/a |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Fisher & Paykel Healthcare Corporation has an Altman Z-Score of 21.13.
Altman Z-Score | 21.13 |
Piotroski F-Score | n/a |